首页> 外文学位 >Mechanistic Study of p23-Mediated Aryl Hydrocarbon Receptor Expression
【24h】

Mechanistic Study of p23-Mediated Aryl Hydrocarbon Receptor Expression

机译:p23介导的芳烃受体表达的机理研究

获取原文
获取原文并翻译 | 示例

摘要

The aryl hydrocarbon receptor (AHR) is a ligand-activated signaling molecule which is involved in diverse biological functions ranging from cancer metastasis to immune regulation. This receptor forms a cytoplasmic complex with Hsp90, p23, and XAP2. We have previously reported that down-regulation of p23 triggers degradation of the AHR protein, uncovering a potentially dynamic event which controls the cellular AHR levels without ligand treatment. Here we investigate the underlying mechanisms for this p23 effect using wild-type HeLa and the p23 knockdown HeLa cells. Reduction of the Hsp90 and XAP2 contents, however, did not affect the AHR protein levels, implying that this p23 effect on AHR is more than just alteration of the cytoplasmic complex dynamics. Association of p23 with Hsp90 is not important for the modulation of the AHR levels since exogenous expression of p23 mutants with modest Hsp90-binding affinity effectively restored the AHR message and protein levels. The protein folding property of p23 which resides at the terminal 50-amino acid region is not involved for this p23 effect. Results from our interaction study using the affinity purified thioredoxin fusion proteins and GST fusion proteins and isothermal titration calorimetry showed that p23 directly interacts with AHR and the interaction surface lies within AHR amino acid 1--216 and p23 amino acid 1--110. Down-regulation of the p23 protein content promotes the ubiquitination of AHR, indicating that p23 protects AHR from the ubiquitin-meditated protein degradation. However, the increased ubiquitination is not through the small ubiquitin-like modifier (SUMO) signaling pathway.;Troubleshooting and optimization were paramount for understanding and evaluating the p23 and AHR interaction. Specifically, the p23 mutant purification, p23: Hsp90 interaction, transient transfection, p23: AHR assay, and ITC study were phases of this research that required extensive time and critical thinking. These topics were further detailed to outline the specific problems encountered and the various steps taken to alleviate or optimize these issues.
机译:芳基碳氢化合物受体(AHR)是一种配体激活的信号分子,参与从癌症转移到免疫调节的多种生物学功能。该受体与Hsp90,p23和XAP2形成细胞质复合物。我们以前曾报道过,p23的下调触发AHR蛋白的降解,从而揭示了潜在的动态事件,该事件无需配体处理即可控制细胞的AHR水平。在这里,我们研究了使用野生型HeLa和p23敲低HeLa细胞对该p23效应的潜在机制。然而,Hsp90和XAP2含量的减少并没有影响AHR蛋白的水平,这意味着p23对AHR的作用不仅仅是改变细胞质复合物动力学。 p23与Hsp90的结合对于AHR水平的调节并不重要,因为具有适度Hsp90结合亲和力的p23突变体的外源表达有效地恢复了AHR信息和蛋白质水平。该p23作用不涉及位于末端50个氨基酸区域的p23的蛋白质折叠特性。我们使用亲和纯化的硫氧还蛋白融合蛋白和GST融合蛋白进行的相互作用研究的结果以及等温滴定量热法显示,p23与AHR直接相互作用,相互作用表面位于AHR氨基酸1-216和p23氨基酸1-110中。 p23蛋白含量的下调促进了AHR的泛素化,表明p23保护AHR免受泛素介导的蛋白降解。然而,泛素化的增加不是通过小的泛素样修饰物(SUMO)信号传导途径来进行的。故障排除和优化对于理解和评估p23和AHR相互作用至关重要。具体而言,p23突变体的纯化,p23:Hsp90相互作用,瞬时转染,p23:AHR分析和ITC研究是该研究的阶段,需要大量的时间和批判性的思考。进一步详细介绍了这些主题,以概述遇到的特定问题以及缓解或优化这些问题所采取的各种步骤。

著录项

  • 作者

    Pappas, Beverly M.;

  • 作者单位

    University of the Pacific.;

  • 授予单位 University of the Pacific.;
  • 学科 Pharmaceutical sciences.;Pharmacology.
  • 学位 Ph.D.
  • 年度 2018
  • 页码 130 p.
  • 总页数 130
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号